Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date |
Article Title |
Journal |
|---|---|---|---|
|
Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi,Michael Weller, Amy B. Heimberger |
September 2021 | Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma | American Association for Cancer Research |
|
Tao Wang, Rong Lu, Sunny Lai, Joan H. Schiller, Fang Liz Zhou, Bo Ci, Stacy Wang, Xiaohan Gao, Bo Yao, David E. Gerber, David H. Johnson, Guanghua Xiao, Yang Xie |
February 2019 | Development and Validation of a Nomogram Prognostic Model for Patients with Advanced Non-Small-Cell Lung Cancer | Cancer Informatics |
|
J. C. Angulo, J. P. Ciria Santos, A. Gómez-Caamaño, R. Poza de Celis, J. L. González Sala, J. M. García Garzón, J. A. Galán-Llopis, M. Pérez Sampietro, V. Perrot & J. Planas Morin on behalf of ANARESISTANCE study group |
September 2022 | Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study | SpringerLink |
|
Michael A. Webster-Clark, Hanna K. Sanoff, Til Stürmer, Sharon Peacock Hinton, Jennifer L. Lund |
January 2019 | Diagnostic Assessment of Assumptions for External Validity - An Example Using Data in Metastatic Colorectal Cancer | Epidemiology |
|
Kaitlyn Johnson, Axel Gomez, Jackson Burton, Douglas White, Arijit Chakravarty, Annette Schmid, Dean Bottino |
November 2018 | Directional Inconsistency Between Response Evaluation Criteria in Solid Tumors (RECIST) Time to Progression and Response Speed and Depth | European Journal of Cancer |
|
Aurélie Lombard, Hitesh Mistry, Leon Aarons, Kayode Ogungbenro |
October 2020 | Dose individualisation in oncology using chemotherapy‐induced neutropenia: Example of docetaxel in non‐small cell lung cancer patients | British Journal of Clinical Pharmacology |
|
Krastan B. Blagoev, Roumen Iordanov, Mengxi Zhou, Tito Fojo, Susan E. Bates |
January 2021 | Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer | Oncotarget |
|
Omar Abdel-Rahman |
November 2019 | ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials | International Journal of Colorectal Disease |
|
Omar Abdel-Rahman |
December 2019 | Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials | Clinical Colorectal Cancer |
|
S. Peter Wu, Moses Tam, Raymond Mailhot Vega, Carmen A. Perez, Naamit Kurshan Gerber |
November 2017 | Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up | Radiation Oncology |
|
Qiyu Wang, Ian A. Strohbehn, Sophia Zhao, Harish Seethapathy, Samuel D. Strohbehn, Paul Hanna, Meghan Lee, Riley Fadden, Ryan J. Sullivan, Genevieve M. Boland, Kerry L. Reynolds, Meghan E. Sise |
August 2022 | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma | ScienceDirect |
|
Warit Ruanglertboon, Michael J. Sorich, Andrew Rowland, Ashley M. Hopkins |
May 2020 | Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients | International Journal of Clinical Oncology |
|
Eric V.Li, Mohammad R.Siddiqui, Adam B.Weiner, Anna E.Prizment, Charles J.Ryan, Alicia K.Morgans |
March 2021 | Efficacy and adverse events of docetaxel for metastatic, hormone-sensitive prostate cancer among elderly men: post-hoc analysis of CHAARTED trial | Clinical Genitourinary Cancer |
|
Omar Abdel-Rahman |
October 2019 | Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel - A pooled analysis of 3 randomized studies | Urologic Oncology: Seminars and Original Investigations |
